{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:15:08Z","timestamp":1788052508594,"version":"build-2784847793"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007613","name":"Ankara University","doi-asserted-by":"publisher","award":["TDK-2023-2877"],"award-info":[{"award-number":["TDK-2023-2877"]}],"id":[{"id":"10.13039\/100007613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020410","name":"Health Institutes of Turkey","doi-asserted-by":"publisher","award":["2022B02-22566"],"award-info":[{"award-number":["2022B02-22566"]}],"id":[{"id":"10.13039\/100020410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119204","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:53:20Z","timestamp":1785772400000},"page":"119204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Some novel benzimidazole and benzoxazole methyl ester derivatives as BCL2 inhibitors and BAX activators: Synthesis, anticancer activity and in silico evaluation"],"prefix":"10.1016","volume":"318","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7632-0997","authenticated-orcid":false,"given":"Gozde Yenice","family":"Cakmak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalcin","family":"Erzurumlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap Yilmaz","family":"Ozguven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkay","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119204_bib1","series-title":"The Molecular Basis of Human Cancer","author":"Coleman","year":"2001"},{"key":"10.1016\/j.ejmech.2026.119204_bib2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41568-023-00594-2","article-title":"Bacteria in cancer initiation, promotion and progression","volume":"23","author":"El Tekle","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119204_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.119204_bib4","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever\u2010increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2026.119204_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejmech.2026.119204_bib6","series-title":"The Cell: a Molecular Approach","author":"Cooper","year":"2019"},{"key":"10.1016\/j.ejmech.2026.119204_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119204_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179570","article-title":"Targeting apoptotic pathways for cancer therapy","volume":"134","author":"Tian","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119204_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejmech.2026.119204_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tcb.2020.03.004","article-title":"Noncanonical cell fate regulation by Bcl-2 proteins","volume":"30","author":"Chong","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119204_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/cdd.2017.170","article-title":"Anti-apoptotic BCL-2 family members in development","volume":"25","author":"Opferman","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.119204_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/cdd.2017.161","article-title":"The BCL-2 arbiters of apoptosis and their growing role as cancer targets","volume":"25","author":"Adams","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.119204_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2174\/0929866523666160719094636","article-title":"A review on structures and functions of Bcl-2 family proteins from Homo sapiens","volume":"23","author":"Sivakumar","year":"2016","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ejmech.2026.119204_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","article-title":"The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy","volume":"10","author":"Vogler","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119204_bib15","first-page":"13","article-title":"Targeting BCL-2 in cancer: advances, challenges, and perspectives","author":"Hafezi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2026.119204_bib16","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-08-2985","article-title":"An open-label, multicenter, phase I\/II study of single-agent AT-101 in men with castrate-resistant prostate cancer","volume":"15","author":"Liu","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119204_bib17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119204_bib18","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1021\/jm800669s","article-title":"Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-Cell lymphoma 2 proteins","volume":"51","author":"Park","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib19","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1182\/blood-2006-10-047951","article-title":"Preclinical studies of the Pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma","volume":"109","author":"Trudel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119204_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119204_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molcel.2010.10.019","article-title":"BH3-triggered structural reorganization drives the activation of proapoptotic BAX","volume":"40","author":"Gavathiotis","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2026.119204_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(00)00008-8","article-title":"Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition","volume":"102","author":"Du","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119204_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119204_bib24","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1097-2765(00)00136-2","article-title":"The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues","volume":"6","author":"Lindsten","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2026.119204_bib25","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/md9091554","article-title":"Synthesis and \u03b1-Glucosidase inhibitory mechanisms of Bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, a potential marine bromophenol \u03b1-Glucosidase inhibitor","volume":"9","author":"Liu","year":"2011","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2026.119204_bib26","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/23730","article-title":"Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis","volume":"400","author":"Yin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119204_bib27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41589-019-0306-6","article-title":"Targeting BAX to drug death directly","volume":"15","author":"Walensky","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119204_bib28","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI118715","article-title":"Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice","volume":"97","author":"Bargou","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119204_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2026.119204_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1200\/JCO.2002.20.3.811","article-title":"Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer","volume":"20","author":"Jansson","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119204_bib31","first-page":"1070","article-title":"Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases","volume":"9","author":"Milas","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119204_bib32","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1007\/s11033-012-1500-8","article-title":"Expressions of GRP78 and Bax associate with differentiation, metastasis, and apoptosis in non-small cell lung cancer","volume":"39","author":"Sun","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejmech.2026.119204_bib33","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.1074\/jbc.M500084200","article-title":"Nicotine inactivation of the proapoptotic function of Bax through phosphorylation","volume":"280","author":"Xin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib34","doi-asserted-by":"crossref","first-page":"18859","DOI":"10.1074\/jbc.M512543200","article-title":"Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation","volume":"281","author":"Xin","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tips.2021.11.001","article-title":"Physiological and pharmacological modulation of BAX","volume":"43","author":"Spitz","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.119204_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nchembio.995","article-title":"Direct and selective small-molecule activation of proapoptotic BAX","volume":"8","author":"Gavathiotis","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119204_bib37","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1021\/jm501123r","article-title":"Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents","volume":"58","author":"Stornaiuolo","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib38","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1038\/ncomms5935","article-title":"Small-molecule Bax agonists for cancer therapy","volume":"5","author":"Xin","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119204_bib39","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/MCB.00996-13","article-title":"Activation of the proapoptotic Bcl-2 protein Bax by a small molecule induces tumor cell apoptosis","volume":"34","author":"Zhao","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119204_bib40","doi-asserted-by":"crossref","first-page":"12083","DOI":"10.1021\/acs.jmedchem.0c01454","article-title":"HDAC-Bax multiple ligands enhance bax-dependent apoptosis in HeLa cells","volume":"63","author":"Liang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib41","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41467-022-28741-7","article-title":"Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer","volume":"13","author":"Lopez","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119204_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115076","article-title":"Optimization of BAX trigger site activator BTSA1 with improved antitumor potency and in vitro ADMET properties","volume":"248","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119204_bib44","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20177974","article-title":"Systematic characterization of pan-cancer mutation clusters","volume":"14","author":"Buljan","year":"2018","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejmech.2026.119204_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910442","article-title":"B cell lymphoma 2: a potential therapeutic target for cancer therapy","volume":"22","author":"Alam","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119204_bib46","series-title":"The Chemistry of Heterocycles Elsevier","first-page":"149","article-title":"Five-membered heterocycles","author":"Ram","year":"2019"},{"key":"10.1016\/j.ejmech.2026.119204_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762807","article-title":"A comprehensive account on recent progress in pharmacological activities of benzimidazole derivatives","volume":"12","author":"Brishty","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119204_bib48","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ejmech.2014.11.064","article-title":"Benzoxazoles and oxazolopyridines in medicinal chemistry studies","volume":"97","author":"Demmer","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16765-4","article-title":"Identification of key interactions of benzimidazole resistance-associated amino acid mutations in Ascaris \u03b2-tubulins by molecular docking simulations","volume":"12","author":"Jones","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119204_bib50","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/ph18081225","article-title":"Benzimidazole\u2013pyrimidine hybrids: synthesis and medicinal properties","volume":"18","author":"Marinescu","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119204_bib51","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s12272-010-0701-8","article-title":"Design, synthesis and biological evaluation of some novel benzimidazole derivatives for their potential anticonvulsant activity","volume":"33","author":"Jain","year":"2010","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2026.119204_bib52","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/1389557517666171101104024","article-title":"Antimicrobial potential of benzimidazole derived molecules","volume":"19","author":"Bansal","year":"2019","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.101139","article-title":"Benzimidazole: a versatile scaffold for drug discovery and beyond\u2013A comprehensive review of synthetic approaches and recent advancements in medicinal chemistry","volume":"6","author":"Mahurkar","year":"2023","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib54","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.bmc.2010.02.037","article-title":"Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives","volume":"18","author":"Tonelli","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113921","article-title":"Coumarin-benzimidazole hybrids: a review of developments in medicinal chemistry","volume":"227","author":"G","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib56","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2174\/1389557522666220104150051","article-title":"A panoramic review of benzimidazole derivatives and their potential biological activity","volume":"22","author":"Hern\u00e1ndez-L\u00f3pez","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib57","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ejmech.2014.01.030","article-title":"Benzimidazole: an emerging scaffold for analgesic and anti-inflammatory agents","volume":"76","author":"Gaba","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13065-019-0625-4","article-title":"Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review","volume":"13","author":"Tahlan","year":"2019","journal-title":"BMC Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib59","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2174\/0115680266314704240522112439","article-title":"Benzimidazole as a privileged scaffold in drug design and discovery","volume":"24","author":"Kumar","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib60","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2174\/1381612824666181017102930","article-title":"Benzimidazole derivatives as potential antimicrobial and antiulcer agents: a mini review","volume":"19","author":"Ganie","year":"2019","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib61","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ejmech.2010.01.007","article-title":"Derivatives of benzimidazole pharmacophore: synthesis, anticonvulsant, antidiabetic and DNA cleavage studies","volume":"45","author":"Shingalapur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14609","article-title":"Benzimidazole-oxadiazole hybrids-development in medicinal chemistry: an overview","volume":"104","author":"Bhat","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.119204_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00894-022-05097-9","article-title":"Design of novel benzimidazole derivatives as potential \u03b1-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation studies","volume":"28","author":"Abchir","year":"2022","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.ejmech.2026.119204_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.101013","article-title":"A critical review of benzimidazole: sky-high objectives towards the lead molecule to predict the future in medicinal chemistry","volume":"6","author":"Banerjee","year":"2023","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cbdd.12462","article-title":"Comprehensive review in Current developments of benzimidazole-based medicinal chemistry","volume":"86","author":"Keri","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.119204_bib66","article-title":"Benzimidazole hybrids as anticancer drugs: an updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021)","volume":"355","author":"Feng","year":"2022","journal-title":"Arch. Pharm. (Weinh.)"},{"key":"10.1016\/j.ejmech.2026.119204_bib67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejmech.2014.11.053","article-title":"Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: a mini-review","volume":"97","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib68","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1021\/acsomega.3c09411","article-title":"Synthesis, anticancer activity, and in silico modeling of alkylsulfonyl benzimidazole derivatives: unveiling potent Bcl-2 inhibitors for breast cancer","volume":"9","author":"Abbade","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119204_bib69","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.apsb.2022.09.010","article-title":"Benzimidazole and its derivatives as cancer therapeutics: the potential role from traditional to precision medicine","volume":"13","author":"Lee","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119204_bib70","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/jhet.3944","article-title":"Synthetic transformations and biological screening of benzoxazole derivatives: a review","volume":"57","author":"Sattar","year":"2020","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib71","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1248\/bpb.27.1462","article-title":"Effects of trifluoromethyl ketones on the motility of Proteus vulgaris","volume":"27","author":"Wolfart","year":"2004","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2026.119204_bib72","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bcp.2005.12.006","article-title":"Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures","volume":"71","author":"Alvesalo","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119204_bib73","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejmech.2003.11.014","article-title":"Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives","volume":"39","author":"Yildiz-Oren","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0223-5234(92)90154-S","article-title":"The synthesis and the structure-activity relationships of some substituted benzoxazoles, oxazolo(4,5-b)pyridines, benzothiazoles and benzimidazoles as antimicrobial agents","volume":"27","author":"Yal\u00e7in","year":"1992","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib75","first-page":"266","article-title":"Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo(4,5-b)pyridine derivatives","volume":"53","author":"Akbay","year":"2003","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2026.119204_bib76","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejmech.2004.02.005","article-title":"Synthesis and study of antibacterial and antifungal activities of novel 1-[2-(benzoxazol-2-yl)ethoxy]- 2,6-diarylpiperidin-4-ones","volume":"39","author":"Ramalingan","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib77","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/jm020984y","article-title":"4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines","volume":"46","author":"Wells","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib78","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.bmcl.2004.03.086","article-title":"2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors","volume":"14","author":"Courtney","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119204_bib79","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00044-024-03190-7","article-title":"Targeting disease with benzoxazoles: a comprehensive review of recent developments","volume":"33","author":"Abdullahi","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119204_bib80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s41061-024-00477-6","article-title":"The benzoxazole heterocycle: a comprehensive review of the Most recent medicinal chemistry developments of antiproliferative, brain-penetrant, and anti-inflammatory agents","volume":"382","author":"Di Martino","year":"2024","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.213930","article-title":"First-row transition metal compounds containing benzimidazole ligands: an overview of their anticancer and antitumor activity","volume":"439","author":"Hern\u00e1ndez-Romero","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119204_bib82","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2174\/1385272825666210208141107","article-title":"Benzimidazole: a multifacted nucelus for anticancer agents","volume":"25","author":"Yogita","year":"2021","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-023-01101-2","article-title":"Targeting apoptosis; design, synthesis and biological evaluation of new benzoxazole and thiazole based derivatives","volume":"18","author":"Helmy","year":"2024","journal-title":"BMC Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib84","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s11030-022-10524-3","article-title":"Design and synthesis of benzimidazole derivatives as apoptosis-inducing agents by targeting Bcl-2 protein","volume":"27","author":"Ilhan","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2026.119204_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020113","article-title":"Design, synthesis, anticancer activity, and solid lipid nanoparticle formulation of Indole- and benzimidazole-based compounds as pro-apoptotic agents targeting Bcl-2 protein","volume":"14","author":"Nagy","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119204_bib86","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejmech.2014.11.053","article-title":"Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: a mini-review","volume":"97","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib87","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119204_bib88","series-title":"Structure Determination of Organic Compounds, Tables of Spectral Data","first-page":"116","article-title":"4.7 halogen compounds","author":"Pretsch","year":"2020"},{"key":"10.1016\/j.ejmech.2026.119204_bib89","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.119204_bib91","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.119204_bib92","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2026.119204_bib93","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib94","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1016\/j.bmcl.2012.10.046","article-title":"Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors","volume":"22","author":"Lee","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119204_bib95","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1021\/jm901272d","article-title":"Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome","volume":"53","author":"Mizuno","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bioorg.2015.09.003","article-title":"Synthesis and biological evaluation of benzimidazole\u2013oxindole conjugates as microtubule-targeting agents","volume":"63","author":"Kamal","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib97","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1016\/j.bmcl.2012.06.022","article-title":"Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors","volume":"22","author":"Jonckers","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119204_bib98","first-page":"157","article-title":"Synthesis and in vivo anti-inflammatory activity of a novel series of benzoxazole derivatives","volume":"1","author":"Srinivas","year":"2010","journal-title":"Der. Chemica. Sinica."},{"key":"10.1016\/j.ejmech.2026.119204_bib99","doi-asserted-by":"crossref","first-page":"14485","DOI":"10.1021\/acs.joc.1c01357","article-title":"Elemental sulfur-promoted benzoxazole\/benzothiazole formation using a C\u2550C double bond as a one-carbon donator","volume":"86","author":"Zhang","year":"2021","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib100","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ajoc.201700618","article-title":"Palladium-catalyzed dehydrogenation of benzyl alcohols for construction of 2-Arylbenzimidazoles \u201cOn Water\u201d","volume":"7","author":"Hikawa","year":"2018","journal-title":"Asian J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib101","series-title":"Aromatische, Heterocyclische Derivate Und Ihre Verwendung Auf Dem Pharmazeutischen Und Kosmetischen Gebiet","author":"Bernardon","year":"1984"},{"key":"10.1016\/j.ejmech.2026.119204_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200489","article-title":"Synthesis and biological evaluation of 2-(Halophenyl)benzoxazole-5-Carboxylic acids as potential anti-inflammatory and cytotoxic agent with molecular docking studies","volume":"19","author":"Thakral","year":"2022","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2026.119204_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010073","article-title":"Inhibition of rho-associated kinase suppresses medulloblastoma growth","volume":"12","author":"Dyberg","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2026.119204_bib104","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3892\/ol.2015.3619","article-title":"Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1","volume":"10","author":"Zhu","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2026.119204_bib105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejmech.2026.119204_bib106","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2026.119204_bib107","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119204_bib108","series-title":"Discovery Studio Visualizer","author":"Biovia","year":"2021"},{"key":"10.1016\/j.ejmech.2026.119204_bib109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminf."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:21:56Z","timestamp":1788049316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":109,"alternative-id":["S0223523426006495"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119204","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Some novel benzimidazole and benzoxazole methyl ester derivatives as BCL2 inhibitors and BAX activators: Synthesis, anticancer activity and in silico evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119204"}}